Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Blueprint Medicines Corp (NQ: BPMC)
61.97 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:18 AM EST, Feb 25, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 10
Open 61.97
Bid (Size) 61.01 (1)
Ask (Size) 63.74 (1)
Prev. Close 61.97
Today's Range 61.97 - 61.97
52wk Range 60.60 - 102.98
Shares Outstanding 43,837,337
Dividend Yield N/A
Performance
YTD
-24.60%
-24.60%
1 Month
-5.26%
-5.26%
3 Month
-21.42%
-21.42%
6 Month
-19.32%
-19.32%
1 Year
-20.17%
-20.17%
Featured News
More News
Shares of cancer-therapy companies skyrocket after Pfizer acquisition news
Shares of gene-therapy companies shot up on Monday after Pfizer Inc. announced it would acquire cancer drug maker Array BioPharma Inc. in a deal worth up to $11.4 billion. Read More
category PFE , ARRY , XBI , and 19 more.
from MarketWatch
Cancer stocks heat up after third big merger in the past month
The third multibillion-dollar buyout of cancer-treatment developers in the past month was a charm for the shares of targeted oncology companies, as Leerink analyst Andrew Berens said Eli Lilly’s deal... Read More
category SNSS , M&A , LOXO , and 24 more.
from MarketWatch
More News
Read More
Blueprint Medicines to Present Updated Data from Phase 2 PIONEER Trial of Avapritinib in Patients with Indolent Systemic Mastocytosis at 2020 AAAAI Annual Meeting
from PR Newswire
Blueprint Medicines to Present at Upcoming Investor Conferences
from PR Newswire
Blueprint Medicines Reports Fourth Quarter and Full Year 2019 Financial Results
from PR Newswire
Blueprint Medicines to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 13, 2020
from PR Newswire
Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor
from PR Newswire
About to Buy Penny Stocks? Look at These 2 Companies First
category DTIL , BPMC , Market News , and 2 more.
from Motley Fool
Blueprint Medicines (BPMC) Q4 2019 Earnings Call Transcript
category Market News , BPMC
from Motley Fool
Notable Thursday Option Activity: BPMC, CACC, BYND
category Stocks
from Market News Video
Investors Snag BPMC 5.6% Cheaper Than Its Secondary Stock Offering
category Stocks
from Market News Video
Blueprint Medicines Enters Oversold Territory (BPMC)
category Stocks
from Market News Video
UPDATE 1-FDA approves Epizyme's treatment for rare tissue cancer
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.